Description
An antagonist of GPR55; inhibits LPI-induced GPR55 signaling (EC50 = 1.076 µM in U2OS cells overexpressing GPR55); inhibits LPI-induced ERK1/2 phosphorylation (IC50 = 328 nM) and receptor-dependent PKCβII translocation at 30 µM
Formal name: 5-phenyl-3-(1-(1-(p-tolyl)cyclopropane-1-carbonyl)piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one
Synonyms: CCG-152883|CID-23612552
Molecular weight: 403.5
CAS: 931695-79-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Cannabinoid Research